News Releases - 2014 Archives
December 5, 2014
ROCHESTER, Minn. — A phase I clinical trial of nivolumab found that the immune-boosting drug is a highly effective therapy for Hodgkin’s lymphoma. The multi-institution[...]
May 22, 2014
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community